Adrenergic Receptor Stimulation Effects on the Cardiovascular System

Alpha Adrenergic Receptor Effects

• The American College of Cardiology notes that alpha-1 receptor stimulation contributes to increased afterload on the heart 1

Beta Adrenergic Receptor Effects

• The American College of Cardiology recommends that beta-1 receptor stimulation increases heart rate, myocardial contractility, AV node conduction velocity, and cardiac output 1
• The American College of Cardiology states that beta-2 receptor stimulation causes vasodilation, particularly in skeletal muscle beds, and decreases peripheral vascular resistance 2

Integrated Cardiovascular Responses to Specific Agents

• The American Heart Association notes that norepinephrine is a potent vasopressor with strong alpha-1 effects, increasing peripheral vascular resistance, and is particularly useful in shock with low systemic vascular resistance 3
• The European Heart Society states that dopamine exhibits dose-dependent effects, with low doses having primarily dopaminergic effects on renal and splanchnic beds, and higher doses having alpha-adrenergic effects 4
• The American Heart Association recommends that dobutamine has relatively selective beta-1 adrenergic effects, increasing myocardial contractility and decreasing peripheral vascular resistance, making it useful in shock with poor myocardial function 3

Clinical Implications and Therapeutic Applications

• The American College of Cardiology notes that beta blockers competitively block catecholamine effects on beta receptors, reducing myocardial oxygen demand by decreasing heart rate, contractility, and blood pressure 1
• The American College of Cardiology states that beta-1 selective blockers primarily affect the heart, while non-selective beta blockers affect both cardiac function and vascular/bronchial smooth muscle 1
• The American Heart Association recommends that beta blockers should be used cautiously in patients with reactive airway disease, and patients with marked AV block, asthma, severe LV dysfunction or heart failure should not receive acute beta blocker therapy 1

Pitfalls and Considerations

• The Society of Critical Care Medicine notes that vasoactive drugs have a narrow therapeutic spectrum and require close monitoring, with titration to minimal efficacious dose and prompt weaning when possible recommended 7